Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17214658 | 1.00 | PTPN1 (0.30) | PTPN1 | |
| SCHEMBL18425328 | 1.00 | PTPN1 (0.30) | PTPN1 | |
| SCHEMBL17214647 | 1.00 | PTPN1 (0.30) | PTPN1 | |
| SCHEMBL18567164 | 1.00 | PTPN1 (0.30) | PTPN1 | |
| SCHEMBL17214657 | 1.00 | PTPN1 (0.30) | PTPN1 | |
| SCHEMBL18416033 | 0.86 | — | — | |
| SCHEMBL18425240 | 0.86 | — | — | |
| SCHEMBL17214656 | 0.86 | — | — | |
| SCHEMBL18567168 | 0.86 | — | — | |
| SCHEMBL18416034 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10407378-B2 | Compound, and flavor and/or fragrance composition containing said compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2019-09-10 | — | — | US | disclosed |
| EP-3135663-A1 | NOVEL COMPOUND, AND FLAVOR COMPOSITION CONTAINING SAID COMPOUND | Takasago International Corporation (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-20170029358-A1 | NOVEL COMPOUND, AND FLAVOR AND/OR FRAGRANCE COMPOSITION CONTAINING SAID COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-02-02 | — | — | US | disclosed |
| US-20170029358-A1 | NOVEL COMPOUND, AND FLAVOR AND/OR FRAGRANCE COMPOSITION CONTAINING SAID COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2017-02-02 | — | — | US | disclosed |
| WO-2015163023-A1 | NOVEL COMPOUND, AND FLAVOR COMPOSITION CONTAINING SAID COMPOUND | 高砂香料工業株式会社 | 2015-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170029358-A1 | NOVEL COMPOUND, AND FLAVOR AND/OR FRAGRANCE COMPOSITION CONTAINING SAID COMPOUND | TAS2R5, TAS2R1, TAS2R20 | PTPN1 4646/4885 |
| US-10407378-B2 | Compound, and flavor and/or fragrance composition containing said compound | OR10J3, TAS2R5, TAS2R1 | PTPN1 4450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.